Click here for links to all Expanded Tables of Contents EXPANDED TABLE OF CONTENTS VOLUME 9, NUMBER 9    SEPTEMBER 2006 TREATMENT HIGHLIGHTS DEVELOPMENT OF ALZHEIMER’S DISEASE IN PATIENTS WITH MEMORY PROBLEMS Patients with memory impairment plus other cognitive impairments are found to be at greater risk for conversion to Alzheimer’s disease over a 3-year period than are patients who are only memory-impaired. RELATIONSHIP DISCORD AND ITS ASSOCIATION WITH DISTRESS AND IMPAIRMENT Relationship discord is found to be associated with distress and a variety of impairments. COURSE OF OVERWEIGHT/OBESITY IN CHILDHOOD Children who are overweight or obese during part or all of the preschool or elementary school period are found to be at increased risk for being overweight or obese at age 12. QUICKSTATS Child Abuse and Neglect PSYCHOPHARMACOLOGY NOTE PREDICTORS OF NONRESPONSE TO MEDICATION TREATMENT OF OBSESSIVE-COMPULSIVE DISORDER Clinical predictors of nonresponse to medication treatment of obsessive-compulsive disorder (OCD) are found to include comorbid major depressive disorder, sexual obsessions, washing compulsions, miscellaneous compulsions, and greater severity of OCD symptoms at the start of treatment. FDA NEWS AND REVIEW Product Safety Information: Warnings have been strengthened in the labeling of all CNS stimulants approved for the treatment of attention-deficit/hyperactivity disorder (ADHD). The warnings include new wording about serious cardiovascular events and psychiatric adverse events. Approval (first-time generic): Venlafaxine Hydrochloride Tablets -- generic Effexor Approval (first-time generic): (a) Lamotrigine Tablets and (b) Lamotrigine Tablets (chewable, dispersible) -- generic Lamotrigine ASSESSMENT Clinical Outcomes in Routine Evaluation — Outcome Measure (CORE-OM) [a psychological therapy outcome measure] RESOURCES Each issue presents descriptions of clinical resources (eg, professional materials, patient handouts) and information on how to receive those materials.